CoChat

Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice.

Carmignac, Virginie, Quéré, Ronan, Durbeej, Madeleine · 2011 · Human Molecular Genetics

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

Muscle atrophy, a significant characteristic of congenital muscular dystrophy with laminin α2 chain deficiency (also known as MDC1A), occurs by a change in the normal balance between protein synthesis and protein degradation. The ubiquitin-proteasome system (UPS) plays a key role in protein degradation in skeletal muscle cells. In order to identify new targets for drug therapy against MDC1A, we have investigated whether increased proteasomal degradation is a feature of MDC1A. Using the generated dy(3K)/dy(3K) mutant mouse model of MDC1A, we studied the expression of members of the ubiquitin-proteasome pathway in laminin α2 chain-deficient muscle, and we treated dy(3K)/dy(3K) mice with the proteasome inhibitor MG-132. We show that members of the UPS are upregulated and that the global ubiquitination of proteins is raised in dystrophic limb muscles. Also, phosphorylation of Akt is diminished in diseased muscles. Importantly, proteasome inhibition significantly improves the dystrophic dy(3K)/dy(3K) phenotype. Specifically, treatment with MG-132 increases lifespan, enhances locomotive activity, enlarges muscle fiber diameter, reduces fibrosis, restores Akt phosphorylation and decreases apoptosis. These studies promote better understanding of the disease process in mice and could lead to a drug therapy for MDC1A patients.

Overview

Integrity signals

Registry

Crossref · 10.1093/hmg/ddq499

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 53 references

Research works printed but not linked: 1

  1. Voit, 2004, The congenital muscular dystrophies, 1203

Cited by

See all 58

Metadata

Authors
Carmignac, V., Quéré, R., & Durbeej, M.
Affiliations
Lund University (SE)
Corresponding author
Carmignac, Virginie
Venue
Human Molecular Genetics
Published
2010-11-17
Volume
20
Issue
3
Pages
541-552
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2106554287
Cited by
58
References
53
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 8 · 2015: 3 · 2014: 7 · 2013: 3 · 2012: 7
FWCI
2.08
Type
journal article
Language
en
Open access
closed
Locations
  • Human Molecular Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
MDC1A, congenital muscular dystrophy, proteasome inhibition, MG132, ubiquitin-proteasome system, muscle atrophy, protein degradation, Akt phosphorylation, ubiquitination, muscle fibrosis, apoptosis, pharmacotherapy
MeSH terms
Animals, Disease Models, Animal, Fluorescent Antibody Technique, Laminin, Leupeptins, Mice, Transgenic, Muscular Atrophy, Muscular Dystrophy, Animal, Phenotype, Phosphorylation, Blotting, Western, Cysteine Proteinase Inhibitors, Polymerase Chain Reaction, Apoptosis, Mice, Knockout, Muscle, Skeletal, Muscle Fibers, Skeletal, Ubiquitin, Proteasome Endopeptidase Complex, Proto-Oncogene Proteins c-akt, Mice, Ubiquitination, Proteasome Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice. https://app.cochat.ai/papers/10.1093/hmg/ddq499
The paper
Carmignac, V., Quéré, R., & Durbeej, M. (2011). Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddq499

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.